2017 Press Releases

Webcast ImageWebcast
Voyager Therapeutics Inc. Jefferies Gene Technology Investor Summit (Replay)
10/12/17 at 3:30 p.m. ET
Voyager Therapeutics Inc. Jefferies Gene Technology Investor Summit
Thursday, October 12, 2017 3:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Voyager Therapeutics Inc. at Chardan Gene Therapy Conference (Replay)
10/10/17 at 9:00 a.m. ET
Voyager Therapeutics Inc. at Chardan Gene Therapy Conference
Tuesday, October 10, 2017 9:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2017 | 2016 | 2015 | 2014
October 06, 2017
Voyager Therapeutics Announces Multiple Data Presentations at the Congress of the European Society of Gene and Cell Therapy
October 03, 2017
Voyager Therapeutics to Present at Investor Conferences in October
September 18, 2017
Voyager Therapeutics Appoints Matthew P. Ottmer as Chief Operating Officer
September 06, 2017
Voyager Therapeutics Announces Positive Results from Ongoing Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease
August 30, 2017
Voyager Therapeutics to Participate in September Investor Conferences
August 08, 2017
Voyager Therapeutics Reports Second Quarter 2017 Financial Results and Corporate Highlights
August 02, 2017
Voyager Therapeutics to Host Second Quarter 2017 Financial Results and Corporate Highlights Conference Call
July 17, 2017
Voyager Therapeutics Announces Publication from the California Institute of Technology of a Second-Generation Gene Therapy Capsid Demonstrating Further Enhanced Gene Transfer to the Brain
June 26, 2017
Voyager Therapeutics Announces Clinical Trial Update with VY-AADC01 for Advanced Parkinson’s Disease
June 02, 2017
Voyager Therapeutics to Attend Upcoming Investor Conferences
June 01, 2017
Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease
May 09, 2017
Voyager Therapeutics Reports First Quarter 2017 Financial Results and Corporate Highlights
May 04, 2017
Voyager Therapeutics to Host First Quarter 2017 Financial Results and Corporate Highlights Conference Call
April 25, 2017
Voyager Therapeutics Announces Additional Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease
March 15, 2017
Voyager Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Corporate Highlights
March 08, 2017
Voyager Therapeutics to Host Fourth Quarter and Full Year 2016 Financial Results Conference call
February 28, 2017
Voyager Therapeutics Supports Rare Disease Day® and Global Movement to Raise Awareness for Rare Diseases
February 13, 2017
Voyager Therapeutics Announces Lead Clinical Candidate Selection for Monogenic Form of Amyotrophic Lateral Sclerosis (ALS)
February 02, 2017
Voyager Therapeutics to Attend Upcoming Investor Conferences
January 25, 2017
Voyager Therapeutics Announces Publication of Vectored Anti-Tau Monoclonal Antibody Study in The Journal of Neuroscience
January 20, 2017
Voyager Therapeutics Announces Updates from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease
January 05, 2017
Voyager Therapeutics Elects Wendy Dixon, Ph.D. and Glenn Pierce, M.D., Ph.D. to Board of Directors
January 03, 2017
Voyager Therapeutics Appoints Jane Pritchett Henderson as Chief Financial Officer